Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

BIND Biosciences begins phase I study of BIND-014 in cancer

Jan. 13, 2011

HPRG-induced downregulation of PlGF shows anticancer potential

Jan. 13, 2011

UCB claims new PI3K inhibitors

Jan. 13, 2011

Seattle Genetics and Pfizer join to develop anticancer antibody-drug conjugates

Jan. 12, 2011

Cylene Pharmaceuticals identifies novel protein kinase inhibitors

Jan. 12, 2011

Antimalarial artesunate has anticancer properties that can be enhanced by combination therapy

Jan. 12, 2011

Enrollment begins in phase III regorafenib trial in gastrointestinal stromal tumors

Jan. 11, 2011

Eusa Pharma obtains FDA priority review status for Erwinaze BLA

Jan. 11, 2011

Abraxis claims new proto-oncogene tyrosine-protein kinase Src inhibitors

Jan. 11, 2011

TopoTarget patents new NAmPRTase inhibitors

Jan. 11, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...